EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›VRA

VRA

Vera Bradley, Inc.

Next earnings Sep 9, 2026 · consensus $-0.08 EPS, $66.6M rev

Last earnings +8.8% on 2026-06-11

Avoid
$3.95
▲ +2.86%
$3.95▲ +90.82%
over 1Y
L $1.80EODHDH $4.26
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.9%
1W+6.2%
1M+19.7%
3M+23.1%
YTD+53.1%
1Y+90.8%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
C-
Valuation
Fair value
Filings
Watch
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 8 analysts
Sell

Conservative balance sheet (liabilities/equity 0.78x); but revenue fell -15.4% YoY.

Revenue (FY2026) $270M · FY2026

Vera Bradley, Inc. shows $270M in FY2026 revenue (-15.4% YoY), a -17.7% net margin, and -36.3% ROE.

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25FY26
Revenue$540M$500M$384M$319M$270M
Gross profit$288M$239M$204M$159M$125M
Operating income$26.9M-$94.9M$11.6M-$28.8M-$31.9M
Net income$17.8M-$59.7M$7.84M-$62.2M-$47.8M
Diluted EPS$0.52-$1.90$0.25-$2.15-$1.71
Net margin3.3%-11.9%2.0%-19.5%-17.7%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$92.0M
EV / EBITDA—
EV / Sales0.3
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-43.3%
FCF yield-12.0%

Quality & risk

ROIC (est.)-19.2%
Free cash flow-$13.3M
Total debt$0.00
Net cash$18.5M
Altman Z-Score2.74 grey
Piotroski F-Score3/9

Capital returns

Buyback yield0.0%
Dividend yield (est.)—
Shareholder yield0.0%
Shares Δ YoY+1.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Earnings results2026-06-11
  2. 10-Q Quarterly report2026-06-11
  3. 8-K Shareholder vote2026-06-09
  4. 8-K Officer / director change2026-04-24
  5. DEF 14A Proxy statement2026-04-24
  6. 8-K Material agreement2026-04-17
  7. 10-K Annual report2026-03-27
  8. 8-K Officer / director change2026-03-13
  9. 8-K Earnings results2026-03-12

Recent filings

all on EDGAR ↗
4Period ending 2026-06-242026-06-26open ↗4Period ending 2026-06-122026-06-16open ↗4Period ending 2026-06-122026-06-16open ↗4Period ending 2026-06-122026-06-16open ↗10-QPeriod ending 2026-05-022026-06-11open ↗8-KPeriod ending 2026-06-112026-06-11open ↗4Period ending 2026-06-082026-06-10open ↗8-KPeriod ending 2026-06-042026-06-09open ↗SDFiling2026-05-29open ↗ARSPeriod ending 2026-01-312026-04-24open ↗DEF 14APeriod ending 2026-06-042026-04-24open ↗8-KPeriod ending 2026-04-242026-04-24open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueA+
GrowthC-
ProfitabilityF
Financial healthC+
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$270M
-15.4% YoY
Net margin
-17.7%
ROE
-36.3%
P/E
—

SEC fundamentals · FY 2026

'22'23'24'25'26

■ revenue · ■ net income, by fiscal year

Revenue$270M-15.4%
Net income-$47.8M+23.1%
Gross profit$125M-21.3%
Operating income-$31.9M-10.8%
Diluted EPS-$1.71+20.5%
Cash & equivalents$18.5M-35.3%
Total assets$234M-23.7%
Total liabilities$102M-19.9%
Stockholders' equity$132M-26.4%
Gross: 46.4%Op.: -11.8%L/E: 0.78x

Frequently asked

Is Vera Bradley, Inc. (VRA) a buy?
VRA currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.78x); but revenue fell -15.4% YoY.
What is Vera Bradley, Inc.'s quality score?
VRA scores 54.99999999999999/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001495320, latest 10-Q filed 2026-06-11) · EODHD · as of 6/26/2026, 7:43:35 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 2 open-market buys · 0 sales

2026-06-24
Dely Mark C
CHIEF ADMINISTRATIVE OFFICER
Tax13.7K @ $3.84$52.6K
2026-06-12
Bickley Ian
Chief Executive Officer
Buy28.9K @ $3.87$112K
2026-06-12
Layding Martin
Chief Financial Officer
Tax14.0K @ $3.46$48.4K
2026-06-12
Layding Martin
Chief Financial Officer
Tax29.4K @ $3.46$102K
2026-06-12
Meslow Andrew
Director
Buy24.9K @ $3.73$93.0K
2026-06-08
Dely Mark C
CHIEF ADMINISTRATIVE OFFICER
Tax1.01K @ $3.08$3.10K
2026-06-08
Dely Mark C
CHIEF ADMINISTRATIVE OFFICER
Award9.11K
2026-06-08
Dely Mark C
CHIEF ADMINISTRATIVE OFFICER
Tax2.91K @ $3.08$8.97K
2026-04-03
Rodriguez Jessica
Director
Award25.1K
2026-04-03
CASHMAN KRISTINA K
Director
Award25.1K
2026-04-03
Layding Martin
Chief Financial Officer
Award88.5K

Earnings history

beat/miss · move
2026-06-11Beat +791.1% est▲ +8.81%8-K ↗
2026-03-12Miss -170.0% est▲ +35.74%8-K ↗
2025-09-11—▼ -7.89%8-K ↗
2025-06-11—▼ -19.15%8-K ↗
2025-03-12—▼ -3.31%8-K ↗
2024-12-11—▼ -11.90%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Vera Bradley Posts Reduced Q1 Loss, Sees ProgressBullish
finance.yahoo.com· 2026-06-11
Vera Bradley, Inc. Q1 2027 Earnings Call SummaryBullish
finance.yahoo.com· 2026-06-11
Vera Bradley (VRA) Q1 2027 Earnings TranscriptBullish
finance.yahoo.com· 2026-06-11
Vera Bradley Q1 Earnings Call HighlightsBullish
finance.yahoo.com· 2026-06-11
Vera Bradley (VRA) Reports Q1 Loss, Tops Revenue EstimatesBullish
finance.yahoo.com· 2026-06-11
Here are the major earnings before the open Thursday
seekingalpha.com· 2026-06-10

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score55 vs 67
Revenue growth-15.4% vs 7.1%
Net margin-17.7% vs 10.5%
Return on equity-36.3% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 6d
Neutral
+0.01
vs typical · 10 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.